| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/08/2002 | US6337328 Bupropion metabolites and methods of use |
| 01/08/2002 | US6337324 Pharmaceutical combination |
| 01/08/2002 | US6337318 Drugs for peptide agonist |
| 01/08/2002 | US6337094 Bioavailability |
| 01/08/2002 | US6337092 Composition and method of preparing microparticles of water-insoluble substances |
| 01/08/2002 | US6337091 To maximally release its drug content in a controlled manner over a long time period while achieving complete dissolution |
| 01/08/2002 | US6337090 Orally administrable solid ribavirin dosage forms and process for making them |
| 01/08/2002 | US6337088 Selecting a bacteriophage having dimensions similar to virus; loading bacteriophage into jacket comprising hollow fiber, sealing top and bottom ends, placing jacket into bath solution, inoculating lawn of bacteria, calculating retention |
| 01/08/2002 | US6337087 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water |
| 01/08/2002 | US6337086 Pressure sensitive adhesive compositions for transdermal drug delivery devices |
| 01/08/2002 | US6337083 Oral delivery method and composition for solid medications or dietary supplements |
| 01/08/2002 | US6337082 For use in foods, cosmetics, drugs, dispersion, suspension, contrast agents |
| 01/08/2002 | US6337076 Applying onto hypertrophic scar a liquid formulation comprising collodion film-forming carrier having dermatologically effective amount of active ingredient capable of reducing size of scar or improving appearance |
| 01/08/2002 | US6337073 Administering intranasally a live, attenuated yellow fever virus to a human for inducing a binding and a neutralizing antibody response to provide immunity |
| 01/08/2002 | US6337067 Water soluble dry compositions |
| 01/08/2002 | US6337065 For therapy of disorders such as sunburn and other skin deterioration that results from dna damage in skin cells |
| 01/08/2002 | US6336935 Disposable thermal body wrap |
| 01/08/2002 | CA2344471C Hydrogen peroxide disinfectant with increased activity |
| 01/08/2002 | CA2294614C Omeprazole sodium salt |
| 01/08/2002 | CA2193087C Topical compositions comprising n-acetyl-l-cysteine |
| 01/08/2002 | CA2170941C Absorbable polyoxaesters |
| 01/08/2002 | CA2143263C Orally administrable raloxifene formulations |
| 01/08/2002 | CA2067228C Drug delivery system, method for preparing the same and use thereof |
| 01/08/2002 | CA2056357C Process for the preparation of a ligand-receptor complex |
| 01/08/2002 | CA2038744C Pharmaceutical composition containing slightly water-soluble drug |
| 01/04/2002 | CA2313430A1 Custom transdermal patches |
| 01/03/2002 | WO2002000839A2 Statement as to federally sponsored research |
| 01/03/2002 | WO2002000820A1 Stable foam for use in disposable wipe |
| 01/03/2002 | WO2002000778A1 The preparation method of a stable polymer aqueous phase-aqueous phase emulsion and its use |
| 01/03/2002 | WO2002000680A2 Cationic steroid derivatives for gene delivery |
| 01/03/2002 | WO2002000406A1 Production method for silicone molded product |
| 01/03/2002 | WO2002000269A1 The use of honey in wound dressings |
| 01/03/2002 | WO2002000268A1 Sprayable wound care compositions |
| 01/03/2002 | WO2002000261A2 Surfactant-containing formulations for extended release of somatotropin |
| 01/03/2002 | WO2002000251A1 Vaccine against foot-and-mouth disease |
| 01/03/2002 | WO2002000246A2 Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency |
| 01/03/2002 | WO2002000243A2 Stabilized interleukin 2 |
| 01/03/2002 | WO2002000228A1 Oxygen-containing ophthalmic composition |
| 01/03/2002 | WO2002000226A1 A synthetic bulk laxative |
| 01/03/2002 | WO2002000220A1 A method for treating septic shock |
| 01/03/2002 | WO2002000219A1 Sustained-release preparations of quinolone antibiotics and method for preparation thereof |
| 01/03/2002 | WO2002000218A2 Methods of treating neutrophil-related diseases with topical anesthetics |
| 01/03/2002 | WO2002000213A1 Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
| 01/03/2002 | WO2002000212A1 Controlled release arginine formulations |
| 01/03/2002 | WO2002000207A1 The controlled release preparation of insulin and its method |
| 01/03/2002 | WO2002000206A2 Tamper-evident capsule system |
| 01/03/2002 | WO2002000205A1 Use of an acetylated pre-gelled starch with a high content of amylose |
| 01/03/2002 | WO2002000204A1 Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
| 01/03/2002 | WO2002000203A1 Topical pharmaceutical formulations and methods of treatment |
| 01/03/2002 | WO2002000201A2 Method for preparing a composition |
| 01/03/2002 | WO2002000200A1 Novel process for preparing crystalline particles |
| 01/03/2002 | WO2002000199A1 Novel process for preparing and harvesting crystalline particles |
| 01/03/2002 | WO2002000198A1 Process for preparing and harvesting crystalline particles |
| 01/03/2002 | WO2002000197A1 Method of making particles for use in a pharmaceutical composition |
| 01/03/2002 | WO2002000196A2 Wet milling process |
| 01/03/2002 | WO2002000195A2 Methods and compositions for treating pain of the mucous membrane |
| 01/03/2002 | WO2002000194A2 Polymeric micelle compositions |
| 01/03/2002 | WO2002000193A2 Multiple stimulus reversible hydrogels |
| 01/03/2002 | WO2002000192A2 Embolization using carbon coated particles |
| 01/03/2002 | WO2002000191A2 Bdellosomes |
| 01/03/2002 | WO2002000189A1 Cosmetic treatment and device |
| 01/03/2002 | WO2002000182A2 Structures and compositions increasing the stability of peroxide actives |
| 01/03/2002 | WO2002000173A2 Methods for use of delivery composition for expanding, activating, committing or mobilizing one or more pluripotent, self-renewing and committed stem cells |
| 01/03/2002 | WO2002000171A2 Composition for delivery of hematopoietic growth factor |
| 01/03/2002 | WO2002000162A2 Drug-delivery systems |
| 01/03/2002 | WO2002000149A1 Polymeric, fiber matrix delivery systems for bioactive compounds |
| 01/03/2002 | WO2002000137A1 Biodegradable vehicles and delivery systems of biologically active substances |
| 01/03/2002 | WO2002000033A1 Confectionery product containing active ingredients |
| 01/03/2002 | WO2001076038A3 Permanent magnet keeper-shield assembly |
| 01/03/2002 | WO2001072669A3 Therapeutic use of polyhydroxy amine derivates |
| 01/03/2002 | WO2001070242A3 Compositions containing molecular iodine |
| 01/03/2002 | WO2001064187A3 Anaesthetic formulations |
| 01/03/2002 | WO2001058472A3 Botulinum toxin pharmaceutical compositions |
| 01/03/2002 | WO2001049314A3 Glp-2 formulations |
| 01/03/2002 | WO2001049270A3 Odor-masking coating for a pharmaceutical preparation |
| 01/03/2002 | WO2001045695A3 Calcium formate for use as a phosphorus binder and a dietary supplement |
| 01/03/2002 | WO2001045676A3 Extended release oral dosage composition |
| 01/03/2002 | WO2001045675A3 Valve for osmotic devices |
| 01/03/2002 | WO2001043749A3 Pharmaceutical implant containing immediate-release and sustained-release components and method of administration |
| 01/03/2002 | WO2001043748A3 Implant composition containing melengestrol acetate and trenbolone acetate |
| 01/03/2002 | WO2001043734A3 Transdermal administration of phenylpropanolamine |
| 01/03/2002 | WO2001043721A3 Dosage forms having a barrier layer to laser ablation |
| 01/03/2002 | WO2001041800A3 Compositions and methods for stabilizing biological molecules upon lyophilization |
| 01/03/2002 | WO2001041737A3 Solid oral dosage form |
| 01/03/2002 | WO2001039748A3 Orally administrable pharmaceutical product and method of fabrication therefor |
| 01/03/2002 | WO2001028587A3 Magnetic targeted carrier |
| 01/03/2002 | WO2001028527A3 Direct compression polymer tablet core |
| 01/03/2002 | WO2001010481A3 Drug dispensing system |
| 01/03/2002 | US20020002364 Osmotic device for the continuous release of active compounds into the fluids of the gastrointestinal tract |
| 01/03/2002 | US20020002360 Methods, systems, and kits for implanting articles |
| 01/03/2002 | US20020002272 Eliciting HCV-specific antibodies |
| 01/03/2002 | US20020002223 Of acrylic polymers, tackifiers and antimicrobial agent, diiodomethyl-p-tolylsulfone; heat stability, allows ethylene oxide sterilization; surgical drapes |
| 01/03/2002 | US20020002201 Administering to a mammal a therapeutically effective amount of 4-ethylamino-2-butynyl cyclohexyl-phenylglycolate and/ or one or more optically active isomers, and salts to treat disorders involving the urethrogenital tract |
| 01/03/2002 | US20020002189 Nicotine therapy method and oral carrier for assuaging tobacco-addiction |
| 01/03/2002 | US20020002186 Pharmaceutical composition |
| 01/03/2002 | US20020002185 Compositions and methods for reducing ocular hypertension |
| 01/03/2002 | US20020002184 Novel process and compound |
| 01/03/2002 | US20020002175 Nasal delivery of apomorphine in combination with glycol derivatives |
| 01/03/2002 | US20020002172 Pharmaceutical formulations |
| 01/03/2002 | US20020002157 Salen-metal complexes having superoxide, catalase and/or peroxidase activity to treat or prevent diseases from cell or tissue damage |